Allergic Asthma Therapeutics Market, By Drug Type, By Route of Administration, and By Region

Description

Allergic Asthma Therapeutics Market is estimated to be valued at USD 7.7 Bn in 2025 and is expected to reach USD 9.47 Bn by 2032, growing at a compound annual growth rate (CAGR) of 3% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 7.7 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	3.00%	2032 Value Projection:	USD 9.47 Bn

Allergic asthma, also known as allergy-induced asthma, is a chronic inflammatory condition Allergic asthma is a breathing condition where the airways you breathe through tighten when someone inhale an allergen. Allergic asthma is when someone develop breathing difficulties from inhaling allergens. It occurs when the airways swell as part of an allergic reaction. Common allergens include pollen, dander and mold spores. This type of asthma is very common in both children and adults. Symptoms of allergic asthma can include shortness of breath, coughing, wheezing, stuffy nose, itchy eyes and a rash. Asthma is a long-term inflammatory lung disease which is caused by inflammation and narrowing in the air passage resulting from environmental and genetic influences. Irritants such as air pollution, aerosol cleaning products, tobacco smoke, wood fires, and strong odors don't cause an allergic reaction. But they may inflame your airways and make asthma symptoms worse. An asthma attack is characterized by tightening of the muscles around the airways (bronchoconstriction), which narrows the airway and makes breathing difficult. The rising incidence of respiratory diseases and the strategic expansions by the key players are expected to propel the growth of global allergic asthma therapeutics market over the forecast period.

Market Dynamics

The rising incidence of respiratory diseases and the growing demand for cost-effective treatments are expected to propel the global allergic asthma therapeutics market growth over the forecast period. Additionally, an increase in pollution levels and an upsurge in cases of chronic obstructive pulmonary diseases (COPD) are other factors boosting the market growth. For instance, on March 16, 2023, according to the World Health Organization (WHO), Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide, causing 3.23 million deaths in 2020.

Key features of the study:

This report provides in-depth analysis of the global allergic asthma therapeutics market, and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global allergic asthma therapeutics market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study are ASLAN Pharmaceuticals, Takeda Pharmaceutical Company Limited, CHIESI Farmaceutici S.p.A., CSL, NIOX, Fountain Therapeutics, Eli Lilly and Company, GSK plc., Infinity Pharmaceuticals, Inc., Mabtech, Kineta Inc., Marinomed Biotech AG, Mycenax Biotech Inc., AstraZeneca, and Panacea Biotec.
Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global allergic asthma therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global allergic asthma therapeutics market

Detailed Segmentation:

Global Allergic Asthma Therapeutics Market, By Drug Type:
- Corticosteroids
- Bronchodilators
- Leukotriene modifiers
- Immunotherapy
- Biologics
- Others
Global Allergic Asthma Therapeutics Market By Route of Administration:
- Oral
- Inhaled
- Others
Global Allergic Asthma Therapeutics Market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- ASLAN Pharmaceuticals
- Takeda Pharmaceutical Company Limited
- CHIESI Farmaceutici S.p.A.
- CSL
- NIOX
- Fountain Therapeutics
- Eli Lilly and Company
- GSK plc.
- Infinity Pharmaceuticals, Inc.
- Mabtech
- Kineta Inc.
- Marinomed Biotech AG
- Mycenax Biotech, Inc.
- AstraZeneca
- Panacea Biotec

Product Code: CMI4019

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Route of Administration
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
- Merger, Acquisition, Collaborations
- Funding and Investment
- Future Prospective
- Regulatory Guideline and Compliances
- Key Developments
- PEST Analysis
- PORTER's Analysis

4. Global Allergic Asthma Therapeutics Market- COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Allergic Asthma Therapeutics Market, By Drug Type, 2020-2032, (US$ Billion)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Corticosteroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Bronchodilators
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Leukotriene modifiers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Immunotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

6. Global Allergic Asthma Therapeutics Market, By Route of Administration, 2020-2032, (US$ Billion)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segments Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Inhaled
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

7. Global Allergic Asthma Therapeutics Market, By Region, 2020-2032, (US$ Billion)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Billion)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Billion)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Billion)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Billion)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Billion)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Billion)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

ASLAN Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
CHIESI Farmaceutici S.p.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
CSL
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
NIOX
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Fountain Therapeutics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
GSK plc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Infinity Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Mabtech
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Kineta Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Marinomed Biotech AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Mycenax Biotech Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Panacea Biotec
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies

9. Section

Research Methodology
About Us